Meinian Onehealth(002044)
Search documents
A股五张图:好野的“犒赏经济”概念股!
Xuan Gu Bao· 2025-12-18 10:34
Market Overview - The overall market sentiment is described as ordinary, with the ChiNext index showing a significant decline of 2.17% while the Shanghai Composite Index slightly increased by 0.16% [1] - Various sectors experienced mixed performances, with notable gains in AI healthcare and retail, while sectors like Hainan and lithium batteries faced declines [1] Reward Economy - The concept of "Reward Economy" has gained attention, defined as consumers purchasing non-essential items or experiences to alleviate work and life pressures, reflecting a growing trend among younger consumers [5][6] - The Chinese潮玩 (trendy toy) market is projected to reach a market size of 110.1 billion yuan by 2026, indicating substantial growth potential [6] AI Healthcare - AI healthcare stocks rebounded strongly, with companies like Luyuan Pharmaceutical and Meinian Health achieving consecutive gains, while the sector overall rose by 4.23% [11] - The catalyst for this surge was the recent upgrade of Ant Group's AI health app, "Antifufu," which has over 15 million monthly active users, positioning it as a leading health management AI app in China [11] Lithography Machine Sector - The lithography machine sector saw a strong opening, particularly for stocks like New Kylin, which experienced significant gains, although the sector ultimately closed down by 0.56% [14][15] Fujian Sector - The Fujian sector displayed mixed results, with strong performances from traditional leaders like Luyuan Pharmaceutical and Jiumu Wang, while other stocks faced declines [18] - The overall Fujian sector rose by 1.23%, contrasting with the Hainan sector, which saw a significant drop of 3.37% [18]
焦点复盘市场现沪强深弱分化行情,商业航天概念卷土重来,“犒赏经济”概念乘风而起
Sou Hu Cai Jing· 2025-12-18 10:06
Market Overview - A total of 61 stocks hit the daily limit up, while 19 stocks faced limit down, resulting in a sealing rate of 76% [1] - The Shanghai Composite Index rose by 0.16%, while the Shenzhen Component Index and the ChiNext Index fell by 1.29% and 2.17% respectively [1] - The total trading volume in the Shanghai and Shenzhen markets was 1.66 trillion, a decrease of 155.7 billion from the previous trading day [1] Stock Performance - Baida Group achieved a six-day limit up streak, while Shengtong Energy and Pinao recorded five and four consecutive limit ups respectively [1][3] - The number of stocks advancing was nearly 2900, with notable performances in the pharmaceutical, banking, and retail sectors [1] - The commercial aerospace concept saw a resurgence, with stocks like Shunhao and Xibu Materials hitting limit up after previous declines [3][5] Sector Analysis - The pharmaceutical commercial sector experienced significant growth due to increased orders amid a rise in respiratory diseases during the winter season [14][15] - The retail sector, particularly driven by the "reward economy," showed strong performance with stocks like Baida Group and Nanjing Shanglv achieving consecutive limit ups [6][12] - The AI healthcare sector remained active, with Ant Group's AI health app "Antifortune" gaining popularity, leading to limit ups for companies like Meian Health and Huaren Health [7][19] Investment Themes - The commercial aerospace sector is highlighted as a strategic emerging industry, with government support and recent rocket launches boosting investor sentiment [5] - The "reward economy" is emerging as a new consumption model among younger demographics, contributing to the growth of related sectors [6][12] - The IP economy is gaining traction, with government initiatives aimed at promoting new consumption models and financial support for innovative businesses [16] Future Outlook - The market is expected to continue experiencing volatility, with a focus on small-cap stocks and growth sectors as larger stocks face profit-taking [9] - The Shanghai Composite Index is attempting to recover above key moving averages, indicating potential for further upward movement if trading volume increases [9]
VIP机会日报AI医疗概念今日拉升 栏目追踪“蚂蚁阿福”相关动态 提及焦点公司涨停
Xin Lang Cai Jing· 2025-12-18 09:59
转自:智通财经 注:智通财经VIP为内容资讯产品,并非投资建议。以下内容仅为资讯价值展示非对相关公 司的推荐建议,非未来走势预测。投资有风险,入市需谨慎。 想要借智通财经VIP前瞻锚定市场热点,12.12大促将是年末屯货 智启2026投研新局的黄金 窗口期。 活动最后1天,栏目限时特惠。多买多省,屯货更"惠"!选订12个月钜惠8折还能叠加满减 券,再享折上折。 贴心提醒,新客有礼!新用户完成注册即可解锁新手专属礼包,助您轻松获取深度财经内 容: 28元单篇解锁券×6张:注册成功立即到账,单篇付费内容随心看; 满318元立减40元:订阅付费资讯直接抵扣,性价比拉满; 满518元立减60元:高端栏目订阅专属福利,省心又省钱! 新客首购再享额外礼赠,订阅 3或6个月加赠对应栏目5天服务期 + 会员专属服务,订阅 12 个月加赠对应栏目30天服务期 + 会员专属服务。 C 厕联社 财经通讯社 | 准确·快速·权威·专业 VIP SHANCE Daily N 机会目报 星期四 18 情绪指数 47 分 | 涨停 71 VS 跌停 8 (含 st) 上证指数 深圳成指 创业板指 3876.37 13053.97 3107 ...
美年健康龙虎榜数据(12月18日)
Zheng Quan Shi Bao Wang· 2025-12-18 09:33
美年健康今日涨停,全天换手率14.08%,成交额31.81亿元,振幅9.45%。龙虎榜数据显示,机构净买入 6866.37万元,深股通净买入8311.12万元,营业部席位合计净买入1873.61万元。 深交所公开信息显示,当日该股因日涨幅偏离值达10.70%上榜,机构专用席位净买入6866.37万元,深 股通净买入8311.12万元。 证券时报·数据宝统计显示,上榜的前五大买卖营业部合计成交9.97亿元,其中,买入成交额为5.84亿 元,卖出成交额为4.13亿元,合计净买入1.71亿元。 | 买/ | 会员营业部名称 | 买入金额(万 | 卖出金额(万 | | --- | --- | --- | --- | | 卖 | | 元) | 元) | | 买一 | 国泰海通证券股份有限公司成都北一环路证券营业部 | 15074.29 | 16.91 | | 买二 | 深股通专用 | 11040.30 | 2729.19 | | 买三 | 国泰海通证券股份有限公司上海松江区中山东路证券营 业部 | 9723.21 | 52.15 | | 买四 | 机构专用 | 7685.31 | 818.94 | | 买五 | 国泰海 ...
美年健康(002044) - 股票交易异常波动公告
2025-12-18 09:32
美年大健康产业控股股份有限公司 股票交易异常波动公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整,没有虚 假记载、误导性陈述或重大遗漏。 一、股票交易异常波动的情况介绍 美年大健康产业控股股份有限公司(以下简称"公司"或"本公司")股票(证 券简称:美年健康;证券代码:002044)连续两个交易日内(2025 年 12 月 17 日、12 月 18 日)收盘价格涨幅偏离值累计超过 20%,根据《深圳证券交易所交 易规则》的有关规定,属于股票交易异常波动情形。 二、公司关注、核实情况的说明 经公司自查并对实际控制人发函就近期公司股票发生异动情况进行了核实, 现就有关情况说明如下: 1.截至本公告披露日,公司前期披露的信息不存在需要更正、补充之处。 证券代码:002044 证券简称:美年健康 公告编号:2025-088 2.公司未发现近期公共传媒报道了可能或已经对本公司股票交易价格产生 较大影响的未公开重大信息。 3.公司近期经营情况正常,内外部经营环境未发生重大变化。 4.经核查,公司和实际控制人不存在关于本公司的应披露而未披露的重大事 项或处于筹划阶段的重大事项。 5.经核查,公司实际控制人在股 ...
美年健康:股票连续两日涨幅偏离值累计超20%
Xin Lang Cai Jing· 2025-12-18 09:30
美年健康公告称,公司股票(证券代码:002044)在2025年12月17日、18日连续两个交易日内收盘价格 涨幅偏离值累计超过20%,属股票交易异常波动情形。经自查,公司前期披露信息无需更正、补充,未 发现公共传媒报道可能影响股价的未公开重大信息,近期经营正常,内外部环境无重大变化,公司及实 控人无应披露未披露重大事项,实控人在此期间无买卖公司股票情形。公司提醒投资者注意风险。 ...
医疗服务板块12月18日涨0.47%,美年健康领涨,主力资金净流入1.72亿元
Zheng Xing Xing Ye Ri Bao· 2025-12-18 09:07
证券之星消息,12月18日医疗服务板块较上一交易日上涨0.47%,美年健康领涨。当日上证指数报收于 3876.37,上涨0.16%。深证成指报收于13053.98,下跌1.29%。医疗服务板块个股涨跌见下表: 从资金流向上来看,当日医疗服务板块主力资金净流入1.72亿元,游资资金净流出4.27亿元,散户资金 净流入2.54亿元。医疗服务板块个股资金流向见下表: 以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。 ...
美年健康今日大宗交易平价成交35万股,成交额210.7万元
Xin Lang Cai Jing· 2025-12-18 08:55
12月18日,美年健康大宗交易成交35万股,成交额210.7万元,占当日总成交额的0.07%,成交价6.02 元,较市场收盘价6.02元持平。 | 权益类证券大宗交易(协议交易) | | | | | | | 团 下载 | | --- | --- | --- | --- | --- | --- | --- | --- | | 交易日期 | 证券代码 | 证券简称 | 成交价格 (元) | 成交量 (万股/万份) | 成交金额 (万元) | 买方营业部 | 卖方营业部 | | 2025-12-18 | 002044 | 美年健康 | 6.02 | 35.00 | | 210.70 西部证券股份有限 | 华安证券股份有限 | | | | | | | | 公司西安东大街证 劳营业部 | 公司广东分公司 | ...
家庭医生概念涨3.86%,主力资金净流入这些股
Zheng Quan Shi Bao Wang· 2025-12-18 08:48
Group 1 - The family doctor concept sector rose by 3.86%, ranking second among concept sectors, with 22 stocks increasing, including a 20% limit up for Shuyupingmin and a limit up for Meinian Health [1] - The top gainers in the family doctor sector included Haixia Innovation, Weining Health, and Sichuang Medical, with increases of 16.39%, 11.11%, and 5.77% respectively [1] - The sector saw a net inflow of 1.544 billion yuan from main funds, with 18 stocks receiving net inflows, and five stocks exceeding 50 million yuan in net inflow [2] Group 2 - The leading stocks in terms of net inflow ratio were Haixia Innovation, Meinian Health, and Weining Health, with net inflow ratios of 14.36%, 13.05%, and 12.89% respectively [3] - The top three stocks by main fund inflow were Haixia Innovation with 489 million yuan, Meinian Health with 415 million yuan, and Weining Health with 347 million yuan [3][4] - The family doctor concept sector had a total of 15 stocks with significant net inflows, indicating strong investor interest [2][3]
AI医疗概念拉升 华人健康、塞力医疗等涨停
Zheng Quan Shi Bao Wang· 2025-12-18 03:46
消息面上,蚂蚁集团旗下AI健康应用"蚂蚁阿福"于12月15日发布后下载量猛增,16日冲上苹果应用榜总 榜第三位。据悉,"蚂蚁阿福"App月活用户规模已超1500万,每天回答用户500多万个健康提问。 据悉,AI医疗是通过机器学习、自然语言处理、计算机视觉等先进技术,对复杂的医疗数据进行深度 分析,辅助临床决策、优化诊疗流程、提升医疗效率的新型医疗体系,具备智能化、高效化、便捷化的 特征,应用前景广阔。根据甲子光年《2024年中国AI医疗产业研究报告》,2023年中国AI医疗行业规 模为973亿元,预计将在2028年达到1598亿元,2022—2028年间的年复合增长率为10.5%。细分市场 中,AI医学影像和AI制药增长较快。机构表示,随着生成式大模型等AI技术的不断发展,AI医疗将逐 步融入覆盖医疗产业各环节。 AI医疗概念18日盘中强势拉升,截至发稿,华人健康20%涨停,美年健康、塞力医疗亦涨停,嘉和美康 涨超9%。 ...